Gülay Büyükköroğlu

Dr. Gülay Büyükköroğlu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
BŞBehiye Şenel
Behiye Şenel
NDNeslihan Demir
Neslihan Demir
GBGülay Büyükköroğlu
Gülay Büyükköroğlu
MYMustafa Yıldız
Mustafa Yıldız
We report the synthesis and applications of a novel N-doped graphene quantum dots (GQDs) using hydrothermal reaction between citric acid and p-aminophenol. The synthesized N-doped GQDs have been characterized physico-chemically and evaluated its antioxidant, antimicrobial, DNA binding and cleavage activities. siRNA loading studies were performed and their effects on cells were evaluated. Obtained results indicate that monodisperse solution of N-doped GQDs has been obtained with particles size ca. ∼10.9 ± 1.3 nm. UV-Vis spectroscopy studies of the interactions between the N-doped GQDs and calf thymus DNA (CT-DNA) showed that the compound interact with CT-DNA via both intercalative and electrostatic binding. The DNA cleavage study showed that the N-doped GQDs cleaved DNA without any external agents. The antioxidant activity of N-doped GQDS was very active when compared to BHT. As the concentration of the compound increased, the antioxidant activity also increased. Cell viability assay demonstrated that the Ndoped GQDs showed cell viability (70%) when the concentration reached 200 μg/mL for A549 and also MDA-MB-231, 150 μg/mL for NIH-3T3 cell lines at 24 h incubation. N-doped GQDs were coated with Eudragit RS 100 and EphA2-siRNA was loaded. As a result of the studies on these formulations, it was concluded that there may be significant effects on A549 cells. The microscopy results revealed that N-doped GQDs was quickly internalized into the cell. Our novel N-doped-GQDs with siRNA are candidate for in situ tumor suppression via DNA and mRNA breakage.

30 April 2013 in Journal of Microencapsulation
Verified
Journal Article
Closed access
EBEbru Başaran
Ebru Başaran
EYEvrim Yenilmez
Evrim Yenilmez
MBMurat Sami Berkman
Murat Sami Berkman
GBGülay Büyükköroğlu
Gülay Büyükköroğlu
YYYasemin Yazan
Yasemin Yazan
In the present study, cyclosporine A (CsA) was successfully incorporated into cationic chitosan nanoparticles by spray-drying method aiming ocular application. Physicochemical characterisation of particles was performed in detail. Among the particles prepared using three types of chitosan with different molecular weights, particles containing chitosan with medium molecular weight was selected for in vivo studies. Selection was dependent on higher incorporation and encapsulation efficiencies of CsA and also better release characteristic in simulated tear fluid. Sheep were used in in vivo studies. Biological samples were collected at predetermined time intervals and were analysed by enzyme immune assay. CsA could be detected in both aqueous and vitreous humour samples for the duration of 72 h. In vivo release profiles indicated prolonged release of active agent from positively charged chitosan formulations. This may be attributed to enhanced residence time at the corneal and conjunctival surfaces.

1 December 2016 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
GBGülay Büyükköroğlu
Gülay Büyükköroğlu
BŞBehiye Şenel
Behiye Şenel
EBEbru Başaran
Ebru Başaran
EYEvrim Yenilmez
Evrim Yenilmez
YYYasemin Yazan
Yasemin Yazan

1 January 2018
Verified
Book Chapter
Closed access
GBGülay Büyükköroğlu
Gülay Büyükköroğlu
DDDevrim Demir Dora
Devrim Demir Dora
FÖFiliz Özdemir
Filiz Özdemir
CHCandan Hızel
Candan Hızel


1 October 2016 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
GBGülay Büyükköroğlu
Gülay Büyükköroğlu
BŞBehiye Şenel
Behiye Şenel
SGSeval Gezgin
Seval Gezgin
TDTan Dinh
Tan Dinh